[HTML][HTML] A human coronavirus evolves antigenically to escape antibody immunity
RT Eguia, KHD Crawford, T Stevens-Ayers… - PLoS …, 2021 - journals.plos.org
There is intense interest in antibody immunity to coronaviruses. However, it is unknown if
coronaviruses evolve to escape such immunity, and if so, how rapidly. Here we address this …
coronaviruses evolve to escape such immunity, and if so, how rapidly. Here we address this …
Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
T Goshen-Lago, I Waldhorn, R Holland… - JAMA …, 2021 - jamanetwork.com
Importance The efficacy and safety profile of SARS-CoV-2 vaccines have been acquired
from phase 3 studies; however, patients with cancer were not represented in these trials …
from phase 3 studies; however, patients with cancer were not represented in these trials …
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited
Published series on COVID-19 support the notion that patients with cancer are a particularly
vulnerable population. There is a confluence of risk factors between cancer and COVID-19 …
vulnerable population. There is a confluence of risk factors between cancer and COVID-19 …
[HTML][HTML] Targeting memory T cell metabolism to improve immunity
Vaccination affords protection from disease by activating pathogen-specific immune cells
and facilitating the development of persistent immunologic memory toward the vaccine …
and facilitating the development of persistent immunologic memory toward the vaccine …
[HTML][HTML] Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Vaccine-mediated immunity often relies on the generation of protective antibodies and
memory B cells, which commonly stem from germinal center (GC) reactions. An in-depth …
memory B cells, which commonly stem from germinal center (GC) reactions. An in-depth …
Differential antibody response to mRNA COVID-19 vaccines in healthy subjects
SE Wheeler, GV Shurin, M Yost, A Anderson… - Microbiology …, 2021 - Am Soc Microbiol
Knowledge about development and duration of virus-specific antibodies after COVID-19
vaccination is important for understanding how to limit the pandemic via vaccination in …
vaccination is important for understanding how to limit the pandemic via vaccination in …
[HTML][HTML] Current developments and challenges of mRNA vaccines
mRNA vaccines have brought about a great revolution in the vaccine fields owing to their
simplicity and adaptability in antigen design, potential to induce both humoral and cell …
simplicity and adaptability in antigen design, potential to induce both humoral and cell …
[HTML][HTML] Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
K Vanshylla, V Di Cristanziano, F Kleipass, F Dewald… - Cell host & …, 2021 - cell.com
Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …
[HTML][HTML] COVID-19 vaccines: Current status and implication for use in Indonesia
Abstract The coronavirus disease 2019 (COVID-19) has inflicted catastrophic damages in
public health, economic and social stability—putting life globally on hold in 2020 and …
public health, economic and social stability—putting life globally on hold in 2020 and …
[HTML][HTML] Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Antibodies, and the B cell and plasma cell populations responsible for their production, are
key components of the human immune system's response to SARS-CoV-2, which has …
key components of the human immune system's response to SARS-CoV-2, which has …